bioZhena Corporation

Femtech: Fertility sensor for women's reproductive self-help tracks menstrual cycle impedance signature for OBGYN, PRIMARY CARE & RE healthcare providers. https://biozhena.files.wordpress.com/2022/06/ovulona-anticipates-and-detects-ovulation-e2022-yellow-txt-below-more-anim-e.ppsx To help any woman to either conceive or to avoid pregnancy naturally, without the need for chemicals, hormones, or surgery. And at the same time conveniently monitoring her cervical health - at home. The biosensor indicating in plain English the fertile window as FERTILE DAY 1, 2, & 3 = OVULATION. Ovulation delay or even ovulation absence caused by stress is detected: https://twitter.com/bioZhena/status/1491136487232274432 Another indication will be: PREGNANT! Yet another: SEE DOCTOR ABOUT ILL CERVIX. FDA 510k clearance is on file for fertility monitoring to aid conception and to provide menstrual cycle data to physicians, useful for patient profiling and as a vital sign (ACOG 2009, NIH DHSS 2014) to manage menstrual problems from teen years to peri-menopause. The 510(k) clears the consumers' #Ovulona™ and the #Ovulograph™ concept for physicians. The Ovulona™, our first already tested tampon-like biosensor, will evolve into a telemetric cervical ring, the Halo™, for automatic effortless monitoring without daily insertion. Used in pregnancy, the Ovulona and/or the Halo will improve management of birthing and prematurity. The bioZhena restart seeks capital financial & human.

• Employees 3
• Founded 2006
• Annual Revenue $2500000